Ketogenic Diet for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
The purpose of this project is to determine if 5 weeks of ketogenic (KD, high-fat) diet vs. standard diet (SD) significantly improves motor and sensory function, glycemic function, and functional independence in patients with spinal cord injury.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the ketogenic diet treatment for spinal cord injury?
Research in rats shows that a ketogenic diet, which is high in fat and low in carbohydrates, can improve motor function and protect nerve cells after a spinal cord injury. Additionally, a pilot study in humans with spinal cord injury found that a ketogenic diet improved motor function and reduced inflammation compared to a standard diet.12345
Is the ketogenic diet safe for humans with spinal cord injury?
Research suggests that the ketogenic diet is generally safe for humans, as it has been used in clinical settings for conditions like epilepsy and shows potential benefits for spinal cord injury recovery. Studies indicate it may improve motor function and reduce inflammation, with no major safety concerns reported.12356
How does the ketogenic diet treatment differ from other treatments for spinal cord injury?
The ketogenic diet is unique because it uses a high-fat, low-carbohydrate approach to promote neuroprotection and improve motor function after spinal cord injury by increasing ketone levels, which serve as alternative energy sources for the brain and help reduce inflammation and protect nerve cells.12347
Research Team
Ceren Yarar-Fisher, PhD
Principal Investigator
Ohio State University
Raquel Minarsch, DPT
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for individuals aged 19-60 with spinal cord injuries, classified as ASIA A, B, C or D. It's not suitable for pregnant women, those with kidney or liver issues, lung diseases, or other neurological/cardiac/vascular conditions that could affect testing.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements are taken within 72 hours of injury, including motor and sensory function, serum glucose, and insulin concentration
Treatment
Participants receive either a ketogenic diet or standard diet for 5 weeks
Follow-up
Participants are monitored for changes in functional independence, serum glucose, and insulin concentration
Treatment Details
Interventions
- Ketogenic Diet
- Standard Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
University of Alabama at Birmingham
Lead Sponsor